Skip to main content
Mission & Vision
  1. Home
  2. About Us
  3. Mission & Vision

Mission & Vision

The Head and Neck Cancer International Group (HNCIG) is dedicated to advancing global research in head and neck cancer through international collaboration, scientific excellence, and innovation in clinical and translational research.

Our mission is to unite leading cooperative groups, research institutions, and clinical investigators worldwide in order to design and deliver high-quality international studies that address the most important unanswered questions in head and neck oncology.

In an era of increasingly personalised medicine, where patient populations eligible for specific therapies and clinical trials are becoming smaller and more complex, international collaboration is essential. HNCIG provides a unique global platform that enables investigators to work together across borders, share expertise, and coordinate research efforts that would not be possible within individual institutions or national networks.

By harmonising research methodologies, facilitating multinational clinical trials, and promoting large-scale collaborative analyses, HNCIG seeks to generate robust scientific evidence that improves clinical practice and advances patient care worldwide.
 

At its core, HNCIG is built on a shared commitment to scientific integrity, collaboration, and the belief that meaningful progress in cancer care can only be achieved through global partnership.

Our mission is realised through:

  • Global scientific collaboration, bringing together cooperative research groups and leading experts in head and neck oncology
  • International clinical trials, enabling efficient evaluation of novel therapeutic strategies across diverse patient populations
  • Harmonisation of research infrastructure, including standardised datasets, methodologies, and study protocols
  • Integration of translational science and data innovation, supporting biomarker discovery, precision oncology, and artificial intelligence-driven research
  • A culture of collaboration and mentorship, supporting both established investigators and the next generation of researchers.

Through these efforts, HNCIG works to accelerate scientific discovery and translate research advances into tangible benefits for patients with head and neck cancer worldwide.

Our Vision

HNCIG envisions a future in which global collaboration drives transformative progress in the prevention, diagnosis, and treatment of head and neck cancers.

Our ambition is to establish HNCIG as the leading international platform for collaborative research in head and neck oncology, enabling the global research community to work together more effectively, share knowledge more rapidly, and generate evidence that improves outcomes for patients everywhere.

By connecting cooperative groups across continents, integrating large-scale datasets, and fostering innovative trial designs, HNCIG aims to transform the way international cancer research is conducted.

The organisation strives to create a dynamic research ecosystem in which clinical investigators, translational scientists, data scientists, and healthcare institutions collaborate seamlessly to address the most pressing challenges in head and neck cancer.

Through this global platform, HNCIG seeks to:

Accelerate therapeutic innovation, enabling rapid evaluation of emerging therapies and combination strategies

  • Generate high-impact scientific evidence, through robust international trials and collaborative research initiatives
     
  • Enable global data collaboration, supporting large-scale data sharing, harmonised registries, and advanced analytical approaches
     
  • Expand access to clinical research, ensuring that patients from diverse healthcare systems and geographic regions can participate in cutting-edge studies
     
  • Foster the next generation of scientific leaders, through mentorship, education, and international collaboration
     
  • Improve survival and quality of life for patients worldwide, translating scientific discovery into meaningful advances in care.

Ultimately, HNCIG seeks to build a truly global research community committed to advancing knowledge, accelerating innovation, and improving the lives of patients affected by head and neck cancer.

Why Global Collaboration Matters in Head and Neck Cancer

Head and neck cancers represent a complex and heterogeneous group of diseases that vary widely in incidence, risk factors, tumour biology, and treatment outcomes across different regions of the world.

Major differences exist in the epidemiology and clinical presentation of these cancers. In some regions, human papillomavirus (HPV) plays a major role in oropharyngeal cancers, while in others, environmental exposures such as tobacco, alcohol consumption, or betel nut chewing remain the predominant risk factors. In certain parts of Asia, Epstein–Barr virus (EBV)–associated nasopharyngeal carcinoma represents a distinct disease entity with unique biological and therapeutic considerations.

These variations create significant challenges for clinical research. Studies conducted within a single country or institution may not adequately capture the diversity of patient populations, tumour characteristics, and treatment practices that exist globally.

At the same time, advances in precision oncology are leading to increasingly specialised treatment strategies based on molecular characteristics and biomarkers. As therapies become more targeted, the number of patients eligible for specific clinical trials becomes smaller, making it increasingly difficult for individual centres or national groups to conduct sufficiently powered studies.

International collaboration therefore becomes essential.

By bringing together cooperative research groups and cancer centres across continents, HNCIG enables studies that would not be feasible within a single healthcare system. Global collaboration allows researchers to recruit larger and more diverse patient populations, improve the generalisability of research findings, and accelerate the evaluation of innovative treatment strategies

In addition, international collaboration helps to:

  • harmonise clinical trial methodologies and research standards
  • facilitate large-scale pooled analyses and meta-analyses
  • accelerate patient recruitment into clinical trials
  • promote equitable access to research participation
  • support the development of global consensus guidelines.

Global Diversity of Head and Neck Cancer

  • HPV-driven disease
  • Tobacco and alcohol-related cancers
  • EBV-associated nasopharyngeal carcinoma
  • Regional variations in clinical practice